sb 203580 has been researched along with tissue plasminogen activator in 1 studies
| Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (tissue plasminogen activator) | Trials (tissue plasminogen activator) | Recent Studies (post-2010) (tissue plasminogen activator) |
|---|---|---|---|---|---|
| 3,489 | 4 | 1,137 | 32 | 1 | 3 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ehrlich, D; Humpel, C; Pirchl, M | 1 |
1 other study(ies) available for sb 203580 and tissue plasminogen activator
| Article | Year |
|---|---|
Ethanol transiently suppresses choline-acetyltransferase in basal nucleus of Meynert slices.
Topics: Analysis of Variance; Animals; Animals, Newborn; Basal Nucleus of Meynert; Central Nervous System Depressants; Chemokine CXCL2; Choline O-Acetyltransferase; Citrulline; Dose-Response Relationship, Drug; Down-Regulation; Drug Interactions; Enzyme Inhibitors; Ethanol; Imidazoles; In Vitro Techniques; Nerve Growth Factor; Neurons; Pyridines; Rats; Thiourea; Time Factors; Tumor Necrosis Factor-alpha | 2012 |